home / stock / dtcff / dtcff news

DTCFF News and Press, Defence Therapeutics Inc Cl A

Stock Information
Company Name: Defence Therapeutics Inc Cl A
Stock Symbol: DTCFF
Market: OTC
Website: defencetherapeutics.com
Menu
Get DTCFF Alerts

News, Short Squeeze, Breakout and More Instantly...
DTCFF - Defence Therapeutics to Participate in Bio International Convention 2026 Next Week for Strategic Partnership Discussions

Montreal, Quebec--(Newsfile Corp. - June 17, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce its participation in the BIO International Co...
DTCFF - Defence Therapeutics Appoints Seasoned Biopharmaceutical Executive Dr John Beaver to Its Board of Directors

Montreal, Quebec--(Newsfile Corp. - June 3, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the appointment of Dr. John Beaver to its...

DTCFF - Defence Therapeutics Appoints Antibody Drug Conjugates Pioneer Dr. John Lambert to Its Board of Directors

Montreal, Quebec--(Newsfile Corp. - June 1, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the appointment of Dr. John Lambert ...

DTCFF - Defence Therapeutics Strengthens Its Scientific Advisory Board with the Appointment of Dr. Sarkis Meterissian

Montreal, Quebec--(Newsfile Corp. - May 29, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC)  ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, announces that Dr. Sarkis Meterissian resigned today ...
DTCFF - Defence Therapeutics Enhances In-House ADC Development Platform with Expanded Analytical and Cellular Testing Capabilities

Montreal, Quebec--(Newsfile Corp. - May 19, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) ("Defence" or the "Company"), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the expansion of internal capabilities to exec...

DTCFF - Defence Therapeutics Announces Grant of Restricted Stock Units

Montreal, Quebec--(Newsfile Corp. - April 24, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a publicly traded biotechnology and precision intracellular drug-delivery company, wishes to announce that the board of directors of th...

DTCFF - Defence Therapeutics Announces Warrant Terms Amendment

Montreal, Quebec--(Newsfile Corp. - March 20, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC) (" Defence " or the " Company "), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce an amendment to the terms of a...
DTCFF - Defence Therapeutics Announces Closing of Private Placement of Units for Gross Proceeds of $9,595,000

Montreal, Quebec--(Newsfile Corp. - March 9, 2026) - Defence Therapeutics Inc. (CSE: DTC) (OTCQB: DTCFF) (FSE: DTC), (" Defence " or the " Company "), a publicly traded biotechnology and precision intracellular drug-delivery company, is pleased to announce the closing of a private place...

DTCFF - Defence Therapeutics to Showcase Accum Platform at Key International Industry Events in March

Montreal, Quebec--(Newsfile Corp. - March 2, 2026) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTCQB: DTCFF) ("Defence" or the "Company"), a publicly traded biotechnology company advancing next-generation therapeutics using its proprietary Accum ® platform, today outlined its partici...

DTCFF - Defence Therapeutics to raise up to $11 million in private placement

2026-02-27 17:10:59 ET More on Defence Therapeutics Inc. Seeking Alpha’s Quant Rating on Defence Therapeutics Inc. Financial information for Defence Therapeutics Inc. Read the full article on Seeking Alpha For further details see: Defence Therapeut...
Next 10